| 000 | 01060 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250516084834.0 | ||
| 264 | 0 | _c20121012 | |
| 008 | 201210s 0 0 eng d | ||
| 022 | _a1558-4623 | ||
| 024 | 7 |
_a10.1053/j.semnuclmed.2011.11.004 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSisson, James C | |
| 245 | 0 | 0 |
_aTheranostics: evolution of the radiopharmaceutical meta-iodobenzylguanidine in endocrine tumors. _h[electronic resource] |
| 260 |
_bSeminars in nuclear medicine _cMay 2012 |
||
| 300 |
_a171-84 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_a3-Iodobenzylguanidine _xadverse effects |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aEndocrine Gland Neoplasms _xdiagnosis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aRadiopharmaceuticals _xadverse effects |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aYanik, Gregory A | |
| 773 | 0 |
_tSeminars in nuclear medicine _gvol. 42 _gno. 3 _gp. 171-84 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1053/j.semnuclmed.2011.11.004 _zAvailable from publisher's website |
| 999 |
_c21677682 _d21677682 |
||